Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001· article· en· New England Journal of Medicine· Medicine
aff
11,512
citations
Works
Every work in the frame. Each row carries the routes that admitted it, because a frame that forgets how it found something cannot be audited.
Route
Field
Type
Language
Year range
to
Screen consensus
Sort
Flags
Screening evidence
Direct labels are sparse and unvalidated. Missing labels are unknown.
1 filter active
10,000+ workspage 1
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016· article· en· New England Journal of Medicine· Medicine
aff
10,101
citations
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
2017· article· en· New England Journal of Medicine· Biochemistry, Genetics and Molecular Biology
aff
9,109
citations
8,133
citations
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008· article· en· New England Journal of Medicine· Medicine
aff
6,637
citations
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
2002· article· en· New England Journal of Medicine· Medicine
aff
6,397
citations
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005· article· en· New England Journal of Medicine· Medicine
aff
5,451
citations
Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen
2000· article· en· New England Journal of Medicine· Medicine
aff
5,268
citations
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006· article· en· Hepatology· Medicine
aff
4,840
citations
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
2014· article· en· New England Journal of Medicine· Medicine
aff
4,611
citations
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002· article· en· The Lancet· Biochemistry, Genetics and Molecular Biology
affno abstract
4,163
citations
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
2018· article· en· New England Journal of Medicine· Medicine
aff
4,044
citations
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
2000· article· en· New England Journal of Medicine· Medicine
aff
4,038
citations
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005· article· en· New England Journal of Medicine· Biochemistry, Genetics and Molecular Biology
aff
3,883
citations
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
2009· article· en· Obstetrical & Gynecological Survey· Medicine
aff
3,658
citations
Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
2003· article· en· New England Journal of Medicine· Medicine
aff
3,565
citations
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
2006· article· en· New England Journal of Medicine· Medicine
aff
3,481
citations
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
2013· article· en· New England Journal of Medicine· Medicine
aff
3,395
citations
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
2017· article· en· New England Journal of Medicine· Medicine
aff
3,390
citations
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
2008· article· en· The Lancet Oncology· Medicine
affno abstract
3,195
citations
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
2000· article· en· JAMA· Medicine
aboutno aff
3,166
citations
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
2000· article· en· New England Journal of Medicine· Medicine
aff
3,010
citations
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
2019· article· en· Journal of Clinical Oncology· Medicine
aff
2,963
citations
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
2012· article· en· The Lancet· Biochemistry, Genetics and Molecular Biology
affno abstract
2,960
citations
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
2021· article· en· The Lancet· Medicine
affno abstract
2,927
citations